RDEA594

DRUG2 trials

Sponsors

Ardea Biosciences, Inc.

Conditions

GoutHyperuricemia

Phase 2

Gout Dose Response Study

CompletedNCT00955981

Ardea Biosciences, Inc.Hyperuricemia

Start: 2009-07-31End: 2011-09-30Updated: 2014-03-07

Allopurinol Combination Study

CompletedNCT01001338

Ardea Biosciences, Inc.Gout

Start: 2009-10-31End: 2016-08-31Updated: 2017-01-24

Related Papers

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol.

2016-01-0764 citations